Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LloydsDirect is a UK digital pharmacy business focused on managing and dispensing NHS repeat prescriptions through an online platform with home delivery. The business was founded in 2015, originally operated as Echo, and later rebranded as LloydsDirect in 2021. Its services center on prescription ordering, GP integration, dispensing, medication reminders, and direct-to-patient delivery rather than developing proprietary therapeutics. In October 2023, Pharmacy2U acquired the business, and LloydsDirect has since been migrated under the Pharmacy2U brand while the underlying legal entity, Metabolic Healthcare, remains active. The company is healthcare-related, but it is not a biotech or drug-development company; it is best understood as a commercial digital pharmacy and health services platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LloydsDirect.